Fmcna Cartersville Chain: Fresenius Medical Care Location: 14 Roving Road Se, Cartersville, Georgia, 30121 Rating: Not Available Phone: (770) 386-8168 |
DSI Cartersville Renal Center Chain: Davita Location: 419 E. Main Street, Cartersville, Georgia, 30120 Rating: Phone: (678) 721-9090 |
Bio-Medical Applications Of Georgia,Llc Chain: Davita Location: 150 Gentilly Boulevard, Cartersville, Georgia, 30120 Rating: Not Available Phone: (770) 276-7192 |
Fresenius Kidney Care - Bartow County Chain: Fresenius Medical Care Location: 60 Slopes Drive, Cartersville, Georgia, 30120 Rating: Not Available Phone: (770) 334-2200 |
News Archive
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the applications for its nCounter® Analysis System, at the American Association for Cancer Research annual meeting.
Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. The findings appear in PLOS ONE.
"It happened quietly, and it didn't make any headlines, but an agreement reached in Geneva last week represents a key step forward in the battle against some of the world's biggest killers: non-communicable diseases (NCDs), including heart disease, cancer, and diabetes," Ambassador Betty King, permanent representative of the United States to the U.N., writes in the U.S. Department of State's "DipNote" blog.
The investigators found that compared to the saline control group, the embryos exposed to ethanol experienced increases in tumor size, tumor blood vessel density, cancer cell infiltration of blood vessels, and VEGF levels.
› Verified 6 days ago
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.